Research Analysts’ Recent Ratings Updates for Albemarle (ALB)

Several analysts have recently updated their ratings and price targets for Albemarle (NYSE: ALB):

• 5/13/2026 – Albemarle had its price target raised by Scotiabank from $200.00 to $215.00.
• 5/12/2026 – Albemarle had its price target raised by Deutsche Bank Aktiengesellschaft from $210.00 to $250.00. They now have a “buy” rating on the stock.
• 5/11/2026 – Albemarle was upgraded by Zacks Research from “hold” to “strong-buy”.
• 5/11/2026 – Albemarle had its price target raised by Royal Bank Of Canada from $245.00 to $253.00. They now have an “outperform” rating on the stock.
• 5/11/2026 – Albemarle had its price target raised by Argus from $185.00 to $230.00. They now have a “buy” rating on the stock.
• 5/11/2026 – Albemarle had its price target raised by Jefferies Financial Group Inc. from $230.00 to $244.00.
• 5/9/2026 – Albemarle was upgraded by Wall Street Zen from “hold” to “buy”.
• 5/8/2026 – Albemarle had its price target raised by UBS Group AG from $230.00 to $264.00. They now have a “buy” rating on the stock.
• 5/8/2026 – Albemarle had its price target raised by Truist Financial Corporation from $245.00 to $260.00. They now have a “buy” rating on the stock.
• 5/8/2026 – Albemarle had its price target raised by Citigroup Inc. from $210.00 to $225.00. They now have a “neutral” rating on the stock.
• 5/8/2026 – Albemarle had its price target raised by Wells Fargo & Company from $165.00 to $200.00. They now have an “equal weight” rating on the stock.
• 5/7/2026 – Albemarle was upgraded by Weiss Ratings from “sell (d-)” to “sell (d+)”.
• 5/7/2026 – Albemarle had its price target raised by Robert W. Baird from $210.00 to $236.00.
• 5/7/2026 – Albemarle had its price target raised by Mizuho from $185.00 to $205.00. They now have a “neutral” rating on the stock.
• 4/28/2026 – Albemarle had its price target raised by Morgan Stanley from $170.00 to $189.00. They now have an “equal weight” rating on the stock.
• 4/27/2026 – Albemarle had its price target raised by HSBC Holdings plc from $200.00 to $220.00. They now have a “buy” rating on the stock.
• 4/24/2026 – Albemarle had its price target raised by Royal Bank Of Canada from $216.00 to $245.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Albemarle had its price target raised by Truist Financial Corporation from $210.00 to $245.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Albemarle was downgraded by Rothschild & Co Redburn from “buy” to “neutral”. They now have a $188.00 price target on the stock.
• 4/21/2026 – Albemarle had its price target raised by Citigroup Inc. from $190.00 to $210.00. They now have a “neutral” rating on the stock.
• 4/21/2026 – Albemarle had its price target raised by Bank of America Corporation from $190.00 to $225.00. They now have a “buy” rating on the stock.
• 4/17/2026 – Albemarle had its “neutral” rating reaffirmed by Robert W. Baird. They now have a $210.00 price target on the stock.
• 4/14/2026 – Albemarle was given a new $189.00 price target by Morgan Stanley.
• 4/13/2026 – Albemarle had its price target raised by Oppenheimer Holdings, Inc. from $216.00 to $222.00. They now have an “outperform” rating on the stock.
• 4/9/2026 – Albemarle had its price target raised by UBS Group AG from $220.00 to $230.00. They now have a “buy” rating on the stock.
• 3/17/2026 – Albemarle was downgraded by Zacks Research from “strong-buy” to “hold”.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Friday, June 12th will be paid a dividend of $0.405 per share. This represents a $1.62 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 12th. Albemarle’s dividend payout ratio (DPR) is presently -47.51%.

Insider Transactions at Albemarle

In other Albemarle news, CEO J Kent Masters sold 11,783 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $170.81, for a total transaction of $2,012,654.23. Following the completion of the transaction, the chief executive officer directly owned 134,628 shares of the company’s stock, valued at approximately $22,995,808.68. This trade represents a 8.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.42% of the company’s stock.

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.